Zhengjia Chen, Ph.D.
Affiliations: | 2009 | Biostatistics | University of Southern California, Los Angeles, CA, United States |
Area:
Biostatistics BiologyGoogle:
"Zhengjia Chen"Parents
Sign in to add mentor| Stanley P. Azen | grad student | 2009 | USC | |
| (Phase I clinical trial designs: Range and trend of expected toxicity level in standard A+B designs and an extended isotonic design treating toxicity as a quasi-continuous variable.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Nazha B, Goyal S, Chen Z, et al. (2020) Efficacy and safety of immune checkpoint blockade in self-identified black patients with advanced non-small cell lung cancer. Cancer |
| Harvey RD, Carthon BC, Lewis C, et al. (2020) Phase 1 safety and pharmacodynamic study of lenalidomide combined with everolimus in patients with advanced solid malignancies with efficacy signal in adenoid cystic carcinoma. British Journal of Cancer |
| Owonikoko TK, Harvey RD, Carthon B, et al. (2020) A Phase I study of safety, pharmacokinetics, and pharmacodynamics of concurrent everolimus and buparlisib treatment in advanced solid tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Sahin IH, Goyal S, Pumpalova YS, et al. (2020) Clinical and molecular markers of immune checkpoint inhibitor (ICI) response in dMMR colorectal cancer (CRC) patients (pts). Journal of Clinical Oncology. 38: 225-225 |
| McCabe C, Patel U, Beardslee T, et al. (2020) The impact of body mass index (BMI) on the safety and outcomes of small molecule inhibitors (SMI) in gastrointestinal cancer. Journal of Clinical Oncology. 38: 144-144 |
| Higgins JP, Lalonde C, Byers KF, et al. (2020) Gemcitabine with carboplatin in metastatic breast cancer: Characterizing outcomes in a modern, real-world population. Journal of Clinical Oncology. 38 |
| Owonikoko TK, Dwivedi B, Chen Z, et al. (2020) YAP1 positive small-cell lung cancer subtype is associated with the T-cell inflamed gene expression profile and confers good prognosis and long term survival. Journal of Clinical Oncology. 38: 9019-9019 |
| Saba NF, Force S, Staley C, et al. (2019) Phase IB Study of Induction Chemotherapy With XELOX, Followed by Radiation Therapy, Carboplatin, and Everolimus in Patients With Locally Advanced Esophageal Cancer. American Journal of Clinical Oncology |
| Paplomata E, Zelnak A, Santa-Maria CA, et al. (2019) Use of Everolimus and Trastuzumab in Addition to Endocrine Therapy in Hormone-Refractory Metastatic Breast Cancer. Clinical Breast Cancer |
| Sahin IH, Chen WH, Chen Z, et al. (2019) Impact of genomic alterations (GAs) on outcomes and their distribution by age groups in metastatic colorectal cancer (mCRC) patients (pts). Journal of Clinical Oncology. 37: 560-560 |